{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:12:18Z","timestamp":1792735938610,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["097395\/Z\/11\/Z"],"award-info":[{"award-number":["097395\/Z\/11\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.parint.2021.102411","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T12:02:43Z","timestamp":1624276963000},"page":"102411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Plasmodium vivax pre-erythrocytic vaccines"],"prefix":"10.1016","volume":"84","author":[{"given":"Arturo","family":"Reyes-Sandoval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10195","key":"10.1016\/j.parint.2021.102411_bb0005","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0140-6736(19)31096-7","article-title":"Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000\u201317: a spatial and temporal modelling study","volume":"394","author":"Battle","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.parint.2021.102411_bb0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/1475-2875-13-481","article-title":"Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900","volume":"13","author":"Rahimi","year":"2014","journal-title":"Malar. J."},{"issue":"6 Suppl","key":"10.1016\/j.parint.2021.102411_bb0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4269\/ajtmh.2007.77.79","article-title":"Vivax malaria: neglected and not benign","volume":"77","author":"Price","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"6","key":"10.1016\/j.parint.2021.102411_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050128","article-title":"Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia","volume":"5","author":"Tjitra","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.parint.2021.102411_bb0025","series-title":"Staying the Course? Malaria Research and Development in a Time of Economic Uncertainty","author":"PATH","year":"2011"},{"issue":"12","key":"10.1016\/j.parint.2021.102411_bb0030","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.4161\/hv.26157","article-title":"Plasmodium vivax malaria vaccines: why are we where we are?","volume":"9","author":"Reyes-Sandoval","year":"2013","journal-title":"Human Vaccin. Immunother."},{"issue":"2","key":"10.1016\/j.parint.2021.102411_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pt.2016.11.001","article-title":"Plasmodium vivax controlled human malaria infection - progress and prospects","volume":"33","author":"Payne","year":"2017","journal-title":"Trends Parasitol."},{"issue":"2","key":"10.1016\/j.parint.2021.102411_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004423","article-title":"Phase 1\/2a trial of Plasmodium vivax malaria vaccine candidate VMP001\/AS01B in malaria-naive adults: safety, immunogenicity, and efficacy","volume":"10","author":"Bennett","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.parint.2021.102411_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099754","article-title":"Plasmodium vivax sporozoite challenge in malaria-naive and semi-immune Colombian volunteers","volume":"9","author":"Arevalo-Herrera","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.parint.2021.102411_bb0050","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4269\/ajtmh.2009.09-0194","article-title":"Successful sporozoite challenge model in human volunteers with Plasmodium vivax strain derived from human donors","volume":"81","author":"Herrera","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.parint.2021.102411_bb0055","series-title":"The Vaccine Industry. Plotkin's Vaccines","first-page":"41","author":"Douglas","year":"2018"},{"issue":"1","key":"10.1016\/j.parint.2021.102411_bb0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1128\/CMR.5.1.26","article-title":"The hypnozoite and relapse in primate malaria","volume":"5","author":"Cogswell","year":"1992","journal-title":"Clin. Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.parint.2021.102411_bb0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pt.2009.12.005","article-title":"Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination","volume":"26","author":"Wells","year":"2010","journal-title":"Trends Parasitol."},{"issue":"20","key":"10.1016\/j.parint.2021.102411_bb0070","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","article-title":"First results of phase 3 trial of RTS,S\/AS01 malaria vaccine in African children","volume":"365","author":"Rts","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"5111","key":"10.1016\/j.parint.2021.102411_bb0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/216160a0","article-title":"Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei","volume":"216","author":"Nussenzweig","year":"1967","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.parint.2021.102411_bb0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4269\/ajtmh.20-0435","article-title":"Immunogenicity and protective efficacy of radiation-attenuated and chemo-attenuated PfSPZ vaccines in equatoguinean adults","volume":"104","author":"Jongo","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.parint.2021.102411_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/hv.6.1.9604","article-title":"A biologist's perspective on malaria vaccine development","volume":"6","author":"Sinden","year":"2010","journal-title":"Hum. Vaccin."},{"issue":"3","key":"10.1016\/j.parint.2021.102411_bb0090","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/eji.200737672","article-title":"Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei","volume":"38","author":"Reyes-Sandoval","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.parint.2021.102411_bb0095","first-page":"158","article-title":"CD8(+) T effector memory cells are a correlate of protection against liver-stage malaria","volume":"131","author":"Reyes-Sandoval","year":"2010","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.parint.2021.102411_bb0100","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.4049\/jimmunol.1100302","article-title":"CD8+ T effector memory cells protect against liver-stage malaria","volume":"187","author":"Reyes-Sandoval","year":"2011","journal-title":"J. Immunol."},{"issue":"43","key":"10.1016\/j.parint.2021.102411_bb0105","doi-asserted-by":"crossref","first-page":"15523","DOI":"10.1073\/pnas.0507413102","article-title":"Plasmodium vivax: recent world expansion and genetic identity to Plasmodium simium","volume":"102","author":"Lim","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4426","key":"10.1016\/j.parint.2021.102411_bb0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.6985745","article-title":"Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite","volume":"207","author":"Yoshida","year":"1980","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.parint.2021.102411_bb0115","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1084\/jem.151.6.1504","article-title":"Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection","volume":"151","author":"Potocnjak","year":"1980","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.parint.2021.102411_bb0120","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1462-5822.2005.00503.x","article-title":"Motility and infectivity of Plasmodium berghei sporozoites expressing avian Plasmodium gallinaceum circumsporozoite protein","volume":"7","author":"Tewari","year":"2005","journal-title":"Cell. Microbiol."},{"issue":"3","key":"10.1016\/j.parint.2021.102411_bb0125","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-4894(92)90215-V","article-title":"Plasmodium gallinaceum: antibodies to circumsporozoite protein prevent sporozoites from invading the salivary glands of Aedes aegypti","volume":"75","author":"Warburg","year":"1992","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.parint.2021.102411_bb0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-12-396548-6.00005-6","article-title":"Malaria vaccine development using synthetic peptides as a technical platform","volume":"114","author":"Corradin","year":"2012","journal-title":"Adv. Immunol."},{"issue":"13\u201314","key":"10.1016\/j.parint.2021.102411_bb0135","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.ijpara.2004.10.009","article-title":"Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein","volume":"34","author":"Herrera","year":"2004","journal-title":"Int. J. Parasitol."},{"issue":"5 Suppl","key":"10.1016\/j.parint.2021.102411_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4269\/ajtmh.2005.73.3","article-title":"Safety and elicitation of humoral and cellular responses in colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine","volume":"73","author":"Herrera","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.parint.2021.102411_bb0145","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1084\/jem.165.4.1160","article-title":"Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine","volume":"165","author":"Barr","year":"1987","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.parint.2021.102411_bb0150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4269\/ajtmh.1989.40.455","article-title":"Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax","volume":"40","author":"Collins","year":"1989","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"6","key":"10.1016\/j.parint.2021.102411_bb0155","doi-asserted-by":"crossref","first-page":"695","DOI":"10.4269\/ajtmh.1991.45.695","article-title":"Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax","volume":"45","author":"Herrington","year":"1991","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"9","key":"10.1016\/j.parint.2021.102411_bb0160","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.vaccine.2008.12.027","article-title":"Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax","volume":"27","author":"Bell","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.parint.2021.102411_bb0165","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1128\/IAI.01667-06","article-title":"A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites","volume":"75","author":"Yadava","year":"2007","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.parint.2021.102411_bb0170","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1128\/IAI.05257-11","article-title":"Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic toll-like receptor 4 agonist formulated in an emulsion","volume":"79","author":"Lumsden","year":"2011","journal-title":"Infect. Immun."}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138357692100129X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138357692100129X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:35:02Z","timestamp":1761302102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138357692100129X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":34,"alternative-id":["S138357692100129X"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2021.102411","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmodium vivax pre-erythrocytic vaccines","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2021.102411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102411"}}